In Vivo Toll-Like Receptor 4 Antagonism Restores Cardiac Function During Endotoxemia

Toll-like Receptor 4 Signaling Confers Cardiac Protection against Ischemic Injury via Inducible Nitric Oxide Synthase- and Soluble Guanylate Cyclase-dependent Mechanisms

(2011) E Wang et al.   ANESTHESIOLOGY

Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus

(2010) Bettina M. Buchholz et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

CD14 is a coreceptor of Toll-like receptors 7 and 9

(2010) Christoph L. Baumann et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*

(2009) Mark Tidswell et al.   CRITICAL CARE MEDICINE

Cardiac dysfunction in severe sepsis and septic shock

(2009) Sergio L Zanotti-Cavazzoni et al.   Current Opinion in Critical Care

Inhibition of Corneal Inflammation by the TLR4 Antagonist Eritoran Tetrasodium (E5564)

(2009) Y. Sun et al.   INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin equine whole blood and monocytes

(2008) Monica D. Figueiredo et al.   AMERICAN JOURNAL OF VETERINARY RESEARCH

TLRs and innate immunity

(2008) B. A. Beutler   BLOOD

Toll-Like Receptors

(2008) Benjamin Erickson et al.   Cardiology in Review

Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis

(2008) Sergio L. Zanotti-Cavazzoni et al.   INTENSIVE CARE MEDICINE

Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

(2008) Pál Pacher et al.   Nature Protocols